baber/WOPTO huggingface dataset:
Patent AU-2011207572-A1 (AU)
Title: Foam wound inserts with regions of higher and lower densities, wound dressings, and methods
Inventor: ROBINSON TIM
IPC: B29C71/02
Filed: 2011-01-19
Abstract: Foam wound inserts with high-density and low-density regions, methods for making wound inserts, wound-treatment methods, and wound-treatment systems.
Patent AU-2011234144-A1 (AU)
Title: 4 - aminopyrimidine derivatives and their use as adenosine A2a receptor antagonists
Inventor: CAMACHO GOMEZ JUAN ALBERTO
IPC: A61P3/10
Filed: 2011-03-29
Abstract: New 4-amino-pyrimidine derivatives as potent antagonists of the adenosine A receptor of formula (I). The invention provides as well a method for preparing such compounds, pharmaceutical compositions comprising an effective amount of these compounds and the use of such compounds in the manufacture of a medicament to treat pathological affections that can be improved by antagonism of the adenosine A receptor.
Patent AU-2011239272-A1 (AU)
Title: Shatterproof container and cap assembly
Inventor: STEIGER JEFFREY H
IPC: B29C45/00
Filed: 2011-10-21
Abstract: SHATTERPROOF CONTAINER AND CAP ASSEMBLY A shatterproof container and cap assembly (10) includes a container body (12) defining a cavity (28) and being formed from polypropylene impact copolymer, and a cap (20) integrally connected to the container body (12). A single annular recess (42) is formed in a lip (24) at an open end (18) of the container body (12). The cap (20) includes first and second sealing flanges (52, 60) that form a generally fluid tight seal with the open end (18) of the container body (12). 30 5T4 6 52 36 do20 '4
Patent AU-2011240646-A1 (AU)
Title: Cementing whipstock apparatus and methods
Inventor: ERVIN DAVID L
IPC: E21B7/08
Filed: 2011-04-13
Abstract: A technique facilitates sidetracking by eliminating one or more trips downhole. The technique comprises delivering a sidetracking system downhole into a wellbore, and utilizing a component of the sidetracking system to grip a wall of the wellbore. The sidetracking system may comprise a whipstock assembly and a running/stinger assembly in which the stinger assembly is designed for disconnection from the whipstock assembly after delivery downhole. After disconnecting the stinger assembly, the sidetracking system enables delivery of cement slurry down through the stinger assembly to form a cement plug at a desired location.
Patent AU-2011241030-A1 (AU)
Title: Mixtures and emulsions for use in providing strength to gypsum compositions
Inventor: STUART JONATHAN T
IPC: C04B28/00
Filed: 2011-02-18
Abstract: Settable gypsum compositions are described herein which include a gypsum slurry, comprising water; and a first additive comprising a vinyl acetate/ethylene copolymer in latex or emulsion form and a second additive which is at least one of (i) a wetting agent and/or a surfactant; (ii) a titanium coupling agent, (iii) a zirconium coupling agent, and (iv) mixtures thereof. The compositions demonstrate improved strength and gypsum core adhesion. Such compositions may also include at least one dispersant and/or a wetting agent and/or a surfactant. Such dispersants may be lignosulfonic acid, naphthalene sulfonic acid, and combinations and salts thereof and the wetting agent and/or surfactant may be N-dodecyl 2- pyrrolidone, ethoxylated alcohol, and combinations thereof. The dispersant and/or wetting agents and/or surfactants can further enhance rheological properties to benefit the enhanced strength gypsum compositions.
Patent AU-2011254079-A1 (AU)
Title: Process for the preparation of rapamycin derivatives
Inventor: ACEMOGLU MURAT
IPC: C07D498/18
Filed: 2011-12-15
Abstract: C -\NRPortDCC\RBR\453714_ _DOC-15/1212011 Processes for the production of a 32-deoxorapamycin from a 32-iodo- or 32 hydroxyrapamycin, wherein the hydroxy group is substituted by the residue of an 5 arylthionocarbonate or an arylthiocarbamate, in the presence of tris(trimethylsilyl)-silan and a.a'-azo-isobutyronitril in organic solvent; and 32-deoxorapamycin in the form of a crystalline solvate.
Patent AU-2011267471-A1 (AU)
Title: Process for the preparation of pteridine derivatives
Inventor: ATTOLINO EMANUELLE
IPC: C07H3/02
Filed: 2011-06-13
Abstract: The application discloses a process for the preparation of 5-deoxy-L-arabinose of formula (VI); comprising the conversion of a compound of formula (XII); wherein n is 0, 1 or 2; which can be used as intermediate for the synthesis of sapropterin.
Patent AU-2011298104-A1 (AU)
Title: Localized congestion exposure
Inventor: ZHANG YING
IPC: H04L47/22
Filed: 2011-07-19
Abstract: A method for localized congestion exposure within a local loop in a cellular network that is performed by a localized congestion exposure receiver node of the local loop. The method includes receiving downlink packets destined for a downstream user device. The downlink packets have headers that indicate a level of congestion experienced by the downlink packets. The headers also indicate a level of expected downstream congestion declared by an upstream node. The method also includes forwarding the downlink packets to the downstream user device through a wireless connection. The method further includes sending packets upstream that have feedback indicative of the level of congestion experienced by the downlink packets and any congestion experienced within the localized congestion exposure receiver node.
Patent AU-2011326394-A1 (AU)
Title: Dexamethasone combination therapy
Inventor: YI QING
IPC: A61K31/5377
Filed: 2011-11-11
Abstract: The present invention relates to a method of treating multiple myeloma in a subject comprising administering to the subject an amount of (1) a compound of formula (I), as described herein, and/or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, and an amount of (2) dexamethasone and/or a pharmaceutically acceptable salt, solvate, metabolite or racemate thereof, such that the subject is treated. In another aspect, provided herein is a method of treating multiple myeloma in a subject comprising administering to the subject an amount of (1) a compound of formula (I) and an amount of (2) dexamethasone, such that the subject is treated; pharmaceutical formulations comprising said combination for the treatment of multiple myelom; and compositions thereof.
Patent AU-2011335034-A1 (AU)
Title: Closed loop monitoring of automated molecular pathology system
Inventor: CORWIN ALEX DAVID
IPC: G01N1/31
Filed: 2011-11-29
Abstract: A closed loop automated method for staining of a biological sample is provided. The method comprises providing a biological sample, staining at least a portion of the biological sample by flowing in a reagent, monitoring one or more optical characteristics of the biological sample, and calculating a figure of merit based on at least one of the optical characteristics. An automated device for iterative staining of a biological sample is also provided.
Patent AU-2011338425-A1 (AU)
Title: Novel modulators and methods of use
Inventor: BANKOVICH ALEX
IPC: C07K16/22
Filed: 2011-12-07
Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
Patent AU-2011338949-A1 (AU)
Title: Blood pressure cuff
Inventor: KINSLEY MATTHEW J
IPC: A61B5/022
Filed: 2011-09-27
Abstract: A blood pressure cuff is defined by a first sheet and a second sheet. The first sheet has a first interior-inflatable surface attached to a second interior-inflatable surface of the second sheet to form an interior-inflatable portion between the first sheet and second sheet. The interior-inflatable portion is in communication with an opening to fluidly interconnect the interior inflatable portion with an exterior of the cuff. A textured surface is included on the second interior-inflatable surface.
Patent AU-2011353038-A1 (AU)
Title: Neuro cardiac therapy using electrical impedance
Inventor: ARCOT-KRISHNAMURTHY SHANTHA
IPC: A61N1/36
Filed: 2011-12-01
Abstract: A device embodiment is configured to deliver vagal stimulation therapy (VST) to a vagus nerve of a patient. The device embodiment includes a neural stimulator, an implantable impedance sensor and an impedance analyzer. The neural stimulator is configured to deliver the VST to the vagus nerve in a cervical region of the patient. The implantable impedance sensor is configured to detect impedance changes in a cervical region of the patient caused by laryngeal vibrations. The impedance sensor is configured to generate sensed impedance values. The impedance analyzer is configured to analyze the sensed impedance values generated by the sensor. The analyzer is configured to detect laryngeal vibrations or cough from the sensed impedance values.
Patent AU-2011359449-A1 (AU)
Title: Intermediate floor, method for producing an intermediate floor and use of an intermediate floor
Inventor: VAN BERS FREDERIK JOHANNES
IPC: E04F15/20
Filed: 2011-02-16
Abstract: The invention relates to an intermediate floor for a floor that is built up of elements laid on the intermediate floor, butting together with their edges. The intermediate floor comprises an intermediate floor layer consisting of an elastic and/or a resilient material. The intermediate floor layer is bonded to an adhesive layer on one side for bonding the elements thereto, which adhesive layer is provided with a protective layer, such as a release sheet, which is detachable so that the elements can be bonded to the adhesive layer. The invention also relates to a method for producing an intermediate floor and to the use of an intermediate floor
Patent AU-2011368630-A1 (AU)
Title: Low-fat mozzarella and process of production thereof
Inventor: BRYSON JENNY LEE
IPC: A23C19/068
Filed: 2011-05-19
Abstract: The invention concerns a process for the production of a low-fat mozzarella comprising the steps of preparing a bulking pre-mix of dry components such as one or a mixture of rennet casein, sodium casein, milk protein concentrate and whey protein concentrate, salt, potassium sorbate and/or sorbic acid, sodium aluminium phosphate, sodium citrate, starch, skim milk powder, and stabiliser; adding said pre-mix to water at ambient temperature; raising the temperature to 80 to 85°C whilst stirring the mixture; and adding natural mozzarella, sequestering agent, and citric acid monohydrate or lactic acid until the mixture is smooth and homogeneous.
Patent WO-2013090992-A1 (WO)
Title: Perfectionnements apportés à des réseaux sans fil
Inventor: PARKER JONATHAN
IPC: H04W40/00
Filed: 2012-12-18
Abstract: L'invention concerne un procédé d'encapsulation de données associées à des requêtes d'adresse URL au niveau d'un serveur pour une transmission sur un réseau WiFi, le procédé comprenant les étapes consistant à créer, par le serveur, une table de page unique par inclusion dans la table de page unique des données associées à de multiples requêtes d'adresse URL reçues au niveau du serveur, le codage de la table de page en un datagramme pour une transmission sur le réseau WiFi étant retardé jusqu'à ce qu'une condition prédéterminée associée à la table de page unique survienne.
Patent AU-2012200272-A1 (AU)
Title: Gas analyzer
Inventor: FURTAW MICHAEL D
IPC: G01L7/00
Filed: 2012-01-17
Abstract: GAS ANALYZER Gas analyzer systems and methods for measuring concentrations of gasses and in particular dry mole fraction of components of a gas. The systems and method allow for rapid measurement of the gas density and/or dry mole fraction of gases for a number of environmental monitoring applications, including high speed flux measurements. A novel coupling design allows for tool-free removal of a cell enclosing a flow path to enable in field cleaning of optical components. CELL AND SENSORS EASILY REMOVED FOR CLEANING CIRCULATION COLUMN 25 PROVIDES AIR PATH BETWEEN SOURCE AND 70 DETECTOR AND 20 MAINTAINS SEPARATION DISTANCE UPON 60-FIG.
Patent AU-2012201518-A1 (AU)
Title: Botulinum toxin screening assays
Inventor: JACKY BIRGITTE P
IPC: C12Q1/00
Filed: 2012-03-14
Abstract: Abstract Methods for detecting BoNT/A activity in a sample, methods for screening molecules able to compete with BoNT/A receptor binding, methods for reducing BoNT/A activity in a human and methods of marketing a neurotoxin capable of selectively binding to FGFR3 to a governmental or regional regulatory authority. C:\NRPotbhDCC\TZM\4206219_1.DOC - 13/3112
Patent AU-2012208922-A1 (AU)
Title: High aspect ratio cellulose nanofilaments and method for their production
Inventor: HUA XUJUN
IPC: D01B9/00
Filed: 2012-01-19
Abstract: A novel method is disclosed to produce on a commercial scale, high aspect ratio cellulose nanofilaments (CNF) from natural lignocellulosic fibers. The method consists of a multi-pass high consistency refining (HCR) of chemical or mechanical fibers using specific combinations of refining intensity and specific energy. The CNF produced by this invention represents a mixture of fine filaments with widths in the submicron and lengths from tens of micrometers to few millimeters. The resultant product is made of a population of free filaments and filaments bound to the fiber core from which they were produced. The proportion of free and bound filaments is governed in large part by total specific energy applied to the pulp in the refiner. These CNF products differ from other cellulose fibrillar materials by their higher aspect ratio and the preserved degree of polymerization (DP) of cellulose. The CNF products made by this invention are excellent additives for the reinforcement of paper, tissue, paperboard and packaging products, plastic composite materials and coating formulations. They display exceptional strengthening power for never-dried paper webs.
Patent AU-2012214166-A1 (AU)
Title: Medical tool with electromechanical control and feedback
Inventor: FRANKHOUSER PAUL L
IPC: A61B17/32
Filed: 2012-02-10
Abstract: A medical device for reducing the force necessary to penetrate living being tissue using a variety of reciprocating motion actuators. The reciprocating actuator drives a penetrating member, such as a needle, through the tissue at a reduced force while the device detects the passage of the penetrating member through the tissue. Upon passage of the penetrating member through the tissue, a feedback system monitors electromechanical properties of a control signal of the device and automatically modifies control based thereon, e.g., electrical power to the reciprocating actuator is automatically terminated.
Patent AU-2012234470-A1 (AU)
Title: Self-binding pigment hybrid
Inventor: GANE PATRICK A C
IPC: D21H17/00
Filed: 2012-03-22
Abstract: The present invention relates to a process for preparing self-binding pigment particles from an aqueous mineral pigment material suspension having a solid content of 45 to 80 wt.-%, based on the total weight of the suspension.
Patent AU-2012240313-A1 (AU)
Title: Solid state forms of HIV inhibitor
Inventor: LI ZHENG JANE
IPC: A61K31/435
Filed: 2012-04-03
Abstract: The invention relates to novel crystalline forms of (2S)-2-tert-butoxy-2-(4-(2,3- dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid, the hydrochloride salt thereof, novel crystalline forms of the hydrochloride salt, methods for the preparation thereof, pharmaceutical compositions thereof and their use in the treatment of Human Immunodeficiency Virus (HIV) infection.
Patent AU-2012244425-A1 (AU)
Title: Adaptable device for electrically isolating pulmonary veins in atrial fibrillation
Inventor: CHIERCHIA GIAN BATTISTA
IPC: A61B18/14
Filed: 2012-04-12
Abstract: Device for electrically isolating the pulmonary veins in atrial fibrillation for treatment thereof by means of ablation of a circumferential zone of tissue in a position where a pulmonary vein extends from an atrium, comprising: a catheter (1) having a terminal part and a distal part and comprising a first tubular element (2); a second tubular element (4) concentric with said first tubular element (2) and an axial rod-like element (6) which extends beyond the distal end of said first and second tubular elements (2; 4); a first tubular toroidal element (13) supported by a plurality of tubular arms (11) which extend from said distal end towards said toroidal element (13) forming a kind of cage which can be opened in umbrella fashion around the distal end of said catheter (1), said tubular arms (11) and said toroidal element (13) being in fluid communication with each other and with said second tubular element (4) of said catheter (1); and a second toroidal tubular element (9) in fluid communication by means of the radial arms (8) with said first tubular element (2) of said catheter (1), all of which so that in a first operating condition said first and second toroidal elements (13; 9) with the associated tubular arms (11) are deflated and made to adhere to said distal end of the catheter; in a second operating condition said distal end of the catheter is inserted inside the orifice of a pulmonary vein (18) and a fluid is pumped into said first toroidal element (13) and into said arms (11) so as to position said arms against the orifice of the said pulmonary vein (18); and in the third operating condition an ablation element is introduced and/or activated inside said second toroidal element (9), inflating it and bringing it into contact with the orifice (18") of the said pulmonary vein (18) for ablation of a circular zone of tissue around the orifice of the said vein.
Patent AU-2012248422-A1 (AU)
Title: Light extraction transparent substrate for organic electroluminescent element and organic electroluminescent element using same
Inventor: NISHIMURA SUZUSHI
IPC: H05B33/02
Filed: 2012-04-25
Abstract: This light extraction transparent substrate for an organic electroluminescent element is provided with a transparent supporting substrate (10) positioned and used on the surface side of the organic electroluminescent element from which light (L) is emitted. A diffraction grating (11) comprising a first concavo-convex layer, with first recesses and projections formed on the surface thereof, is provided on the surface side of the transparent supporting substrate (10), when used for the organic electroluminescent element, serving as a surface (10A) into which the light (L) from the organic electroluminescent element enters. A micro lens (12) comprising a second concavo-convex layer, with second recesses and projections formed on the surface thereof, is provided on the surface side of the transparent supporting substrate (10), when used for the organic electroluminescent element, serving as a surface (10B) from which the light (L) from the organic electroluminescent element exits. When Fourier transform images are obtained from the respective shapes of the first and second recesses and projections by carrying out two-dimensional high-speed Fourier transform processing on concavo-convex analysis images, which are obtained by analyzing the shapes of the first and second recesses and projections with an atomic force microscope, the Fourier transform images show a circular or toric pattern substantially centered on a point of origin where the absolute value of the wave number is 0 μm
Patent AU-2012275503-A1 (AU)
Title: Drive system for a transportation system
Inventor: WAMBLE III JOHN LEE
IPC: B60L13/03
Filed: 2012-06-26
Abstract: A transport system (100) including at least one guideway (200), at least one levitation generator (410, 430), at least one lifting member (420), at least one drive generator (512,514), and at least one drive member (520) is presented.
Patent AU-2012282294-A1 (AU)
Title: Components of a railway rail fastening assembly
Inventor: COX STEPHEN JOHN
IPC: E01B9/30
Filed: 2012-06-27
Abstract: An anchoring device 1, for use in a railway rail fastening assembly which employs a resilient railway rail fastening clip to fasten a railway rail, comprises a body 10 having a front portion 100, which is configured to provide a first load bearing surface 11 which extends alongside the rail foot when the device 1 is in use, and first and second side faces 12A, 12B respectively located on opposite sides of the body 10 and configured to extend transversely away from the first portion 100. The device 1 further comprises first and second projecting portions 13A, 13B, the first projecting portion 13A extending outwardly from the first side face 12A of the body 10, the first projecting portion 13A providing a first additional load bearing surface 130A which is set back from the first load bearing surface 11, and the second projecting portion 13B extending outwardly from the second side face 12B of the body 10, the second projecting portion 13B providing a second additional load bearing surface 130B which is set back from the first load bearing surface 11. A component 2 for use with such an anchoring device 1 comprises first and second sections 21, 22 each having a front part 210, 220, the front parts 210, 220 providing respective first and second auxiliary load bearing surfaces 21 0A, 220A, and a third section 23 interconnecting respective rear parts 214, 224 of the first and second sections 21,22 so that the first and second sections 21, 22 are spaced apart whereby the component 2 can be mounted on such an anchoring device 1 such that the first and second sections 21, 22 are on opposite sides thereof, the front parts 210, 220 of each of the first and second sections 21, 22 having respective rear contact faces 210B, 220B, opposite to the auxiliary load bearing surface 210A, 220B thereof, for contacting the additional load bearing surfaces 130A, 130B of the anchoring device 1 when mounted thereon.
Patent AU-2012283207-A1 (AU)
Title: Pulsed electric field treatment process and dairy product comprising bioactive molecules obtainable by the process
Inventor: MATHYS ALEXANDER
IPC: A23L3/32
Filed: 2012-07-06
Abstract: The present invention addresses the problem of inactivation of bioactive components in milk during pasteurization for preservation. The invention discloses a method of pulsed electric field (PEF) treatment of whole milk, skimmed milk, semi-skimmed milk or whey, or other liquid compositions comprising milk components or fractions. The invention is based on the finding that by selecting one or more specific process parameters, such as the PEF treatment chamber design, the specific energy applied, the field strength, pulse type, start temperature, it is possible to effectively eliminate microorganisms from the composition while conserving the activity of bioactive components in the composition.
Patent AU-2012286648-A1 (AU)
Title: Progesterone antagonists
Inventor: NICKISCH KLAUS
IPC: C07J21/00
Filed: 2012-07-30
Abstract: Described herein are compounds which either act as pure antiprogestins or as antiprogestins with partial agonistic activity and methods of treating cancer using such compounds.
Patent AU-2012294959-A1 (AU)
Title: Conduit connector for a patient breathing device
Inventor: GULLIVER LAURENCE
IPC: A61M16/00
Filed: 2012-08-10
Abstract: In an embodiment, a connector or connector assembly for attaching a nasal cannula with a gas delivery hose includes a sensor port for a sensor probe positioned near an end of a nasal cannula, which can allow the sensor probe to be placed closer to the patient's nostrils than previous connector parts allowed. In an embodiment, the connector is configured to advantageously allow the nasal cannula to rotate relative to the gas delivery hose, thereby allowing a patient or healthcare provider to untangle or otherwise straighten the hose or the cannula. In an embodiment, the connector assembly is configured to automatically align locking protrusions on a first component with locking recesses on a second component, where insertion of the second component within the first component causes the second component to rotate relative to the first component, thereby aligning the locking protrusions with associated locking recesses.